Latest News and Press Releases

TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based...

MediPharm Labs pharma-quality CBD dominant oil line has been awarded CBD Brand of the year by KIND Magazine.MediPharm Labs’ CBD products have seen steady revenue growth and notoriety in 2021,...

Strong cash balance and continued reduction of convertible debt to less than $500K.Opportunities for optimization of the operating strategy between Australia and Canada as the Canadian Drug...

BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in...

Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.This marks the fourth new country entered by MediPharm Labs in 2021, following...

A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects.New CBN products include CBN:CBD 1:2...

BARRIE, Ontario, Nov. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based...

TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based...

C-Suite healthcare leader, Bryan Howcroft, to lead MediPharm’s next phase of international growth as CEO. Bryan will apply his experience in registering, distributing, and selling medically...

New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis business unit of Sanity GroupVayamed is a well-established operating medical cannabis company...